See also this year's filing and all EDGAR filings for this company.
PDF Report 0001637715_2023_Reneo_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001637715, Reneo Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 106,353,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 453,000 |
| 3 | remainder_Assets | 1,376,000 |
| 4 | LiabilitiesCurrent | 7,124,000 |
| 5 | LiabilitiesNoncurrent | 1,059,000 |
| 6 | remainder_Liabilities | 29,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,143,000 |
| 9 | ResearchAndDevelopmentExpense | 37,705,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,893,000 |
| 13 | remainder_ComprehensiveNetIncome | -77,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 108,182,000 |
| 1 | Liabilities | 8,212,000 |
| 2 | Expenses | 53,848,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 99,970,000 |
| 5 | NetIncome | -51,955,000 |
| 6 | ComprehensiveNetIncome | -51,993,500 |
| 7 | BaseVar | 86,106,000 |
| 8 | EconomicCapitalRatio | 2.06 |
Edgar->Model Mapping
Feature Distribution
Change over Time
